|
|
 |
HISTIDINE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
HYPROMELLOSE 2910 Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
IDHIFA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
INBRIJA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|